Member Info for BasilAlderman

We should be hearing news on several fronts soon, including Lord Wellesley's CEO role, the roll-out of the GS20 Exchange, Angra Global, FCA Innovation Pathway & the integration of the EasySend acquisition. Will we get all in one go or a series of RNS announcements? News must be due soon.

Yes and the company has been clear that it is a "Discovery". HE1 Tweeted a few days ago: *" to outline the path to commercialisation for our #helium discovery".

Yes and i would not wish to see VAL appoint as a NED the N4P director, Luke Cairns, as per the RNS yesterday. N4P have had a torid share price implosion from 30p+ to 0.7p. A lot of waffle about collaborations and improving share holder value over many years has come to nothing at N4P. Quite the reverse. Hopefully he will withdraw his candidature prior to the EGM.

There is very big news emerging today from our neighbour, Noble Helium, confirming the "phenomenal potential" of Mbelele and that it is 6 times bigger than initially thought. They have issued an RNS confirming that there is a "Significant probable free gas cap at Mbelele" and that it is "attracting significant interest". The highlights are as follows:

1. Probable free gas cap at Mbelele six times larger than originally mapped.

2. Probable free gas cap could underpin short term monetisation option on a standalone basis.

3. EOI process for low-cost drilling kit for appraisal program attracting significant interest.

4. Well logs now integrated with seismic and structural data shows the probable free gas cap at Mbelele

is emerging as a major structural feature stretching up to 9km north to south and 3km east to west.

5. Early analysis indicates the probable gas cap lies approximately 85m below surface at the crest of

the Mbelele structure, with evidence for a gas column up to 20m in high flow-potential reservoir.

6. The entire structure is readily accessible & could facilitate a very low-capex development.

7. The Company is now preparing to sample and flow test the probable free gas cap and underlying

helium saturated water in the Middle and Lower Lake Beds at Mbelele.

8. Modelling, well design and sourcing of onsite testing facilities are advancing well with the EOI process for fit-for-purpose locally based low-cost drilling equipment attracting significant interest.

9. Noble Helium Executive Chairman Shaun Scott is quoted as follows: “Our ongoing analysis of the probable free gas cap at Mbelele is now revealing a significant structure with strong potential to take us down the monetisation path. Planning and procurement is well underway to appraise Mbelele while negotiations are advancing with potential off-takers to manage logistics and fund downstream facilities. Amid growing global demand for helium I am excited about

North Rukwa’s phenomenal potential and what it means for the Company.”

This begs the question: Just how big is the next RNS going to be from HE1? On the basis of what Noble has just announced to the ASX you would have to conclude that the news from HE1 is going to be very significant.

In simple speak the time has surely come to shout from the rooftops that there are better candidates for Chair, CEO and NED's out there to take VAL forward.

Luke Cairns, Executive Director of N4p, now also a Non Exec at VAL.

If this is the same Luke Cairns from N4p then it's worth flagging up that things have not exactly gone swimmingly well at N4 Pharma. The SP has gone from over 34p to 0.70p

Background: "Luke Cairns, previously a Non-Executive Director of the Company, has been appointed to an Executive Director position. Luke will be overseeing the company's finance and investor relations activities, thereby allowing Nigel Theobald, Chief Executive Officer, more time to focus on driving the Company's development programmes and potential commercial collaborations". Hmmm.

Bearing in mind that BOTB multibagged over x 71,

GGP multibagged over x 63,

EUA multibagged over x 36,

VCP multibagged over x 63,

ESG multibagged over x 41,

NCYT multibagged over x 100,

SNG multibagged over x 100,

SAR multibagged over x 30,

TPST multibagged over x 39

and ARB multibagged over x 100 you woud have to conclude that if they can do it then so can HE1 if and when we get big news of a JV or M&A activity.

Having been invested in GGP when they signed their JV agreement with Newcrest I can vouch for the mega rise that happened from under 3p to over 35p. The really lucky ones were those invested in GGP since the 0.55 days of 2018 who saw a x 65 increase in their holding. "Mega Multi-Bags" do happen, as the above companies highlight. Your 100p a share prediction is probably pushing it but 30p a share to 50p a share is possible if we are valued as a £Billion to £2 Billion Pound + company. e.g. RKH (Rockhopper 13p to 550p) and Greatland (GGP 3p to 35p) both had £Billion valuations for a time when they experienced their monumental share price gains.

In a nutshell, it can and does happen, especially when you factor in the size of the helium & hydrogen resources being talked about. e.g. Noble are believed to have discovered about $4.5 Billion worth of helium in the ground from just one target, which is the adjacent well to HE1's Itumbula West-1. Hence the excitement of "a company making discovery". Noble is basing this on a 2-3% helium flow rate. We've announced a 4.7% helium flow rate. Therefore, HE1 could be worth $Billions on this basis. So, a 30p a share to 50p a share / a 1 Billion to 2 Billion Pound valuation then comes in to play. Great news if your are a HE1 shareholder!

Yes, HEMO needed funds to progress its HEMO-CAR-T clinical trial. That's been achieved. Off to the clinic we go. It's also best to go into future licencing negotiations with a strong hand rather than without cash.

The $4.2 Million placing today ensures that we are now a clinical company. That makes HEMO much more valuable moving forward. Today was a frustrating day but tomorrow is another day.

In summary, the future looks much brighter now that we are progressing HEMO-CAR-T immunotherapy in clinical trials.

Yes, it looks as though HE1 could be the next small cap to enter the "Mega Multi-Bag Hall of Fame", joining such luminaries as BOTB which multibagged x 71 at 7,130%, GGP which multibagged x 63 at 6,300%, EUA which multibagged x 36 at 3,650%, VCP which multibagged x 63 at 6,312% & ESG which multibagged x 41 at 4,190%.

The best (and most pertinent) JV mega gain was when Greatland (GGP) signed their JV agreement with Newcrest. GGP's share price went from under 3p to over 35p and for those invested in GGP since the 0.55 days of 2018 saw a x 65 increase in their holding. Now that's what you call a "Mega Multi-Bag". Will HE1 be next? All the signs are looking good.

Yes and Noble Helium are talking about $4.5 Billion worth of helium in the ground from just one target, which is the adjacent well to HE1's Itumbula West-1. They are using wording such as "a company making discovery" etc and this is based on 2-3% helium flow rate. We've announced a 4.7% helium flow rate. Let that sink in! In summary, HE1 could be worth $Billions on this basis.

Yes, FDA approval opens the door to big pharma licencing deals. They don't deal with companies without FDA consent. It also establishes credibility in the sector. i.e. A deal is far more likely to be agreed today than it was yesterday. We have cash in the bank and FDA approval. Bingo.

Maybe a rumour that the TLW helicopter with Rahul Dhir and a JV doco in his briefcase has landed on the HE1 helipad in Tanzania ! More likely, however, that a JV will be with Exxon, Air Liquide, APD etc but you never know until the RNS arrives. I'm biding my time here waiting for the BIG news.

Yes, that an interesting observation. Perhaps TLW will look to diversify in to Helium?! TLW's CEO Rahul Dhir appears prominently on Lorna's LinkedIn page, full of praise for her career achievements to date. We know she is well connected. More likely imo that a jv will be with a major helium or hydrogen player but your TLW mention is certainly an interesting shout. A JV from a multi-national would see HE1 way past 10p a share.

The 2p Placing Price is 100% up from June 2023 when HEMO was just 1p a share. For those buying in during the 1p to 1.5p share price days just 6 months ago the 2p raise is still at a premium. As & when data is released from the HEMO-CAR-T trial we will achieve the much anticipated inflection point. We are now a clinical company and that is what big pharma is interested in from a licencing point of view. i.e. HEMO will be able to share its data/research with prospective licencing partners. The market was clearly spooked that a placing was on the way after the FDA news and we didn't therefore get the boost in share price we / many expected. Now that the $4.2 million placing has been completed as and when we get more news the share price should rise. Today is a frustrating day but HEMO need funds to progress trials until a major player licences HEMO-CAR-T. It's also best to go into future negotiations with a strong hand rather than without cash. All is still to play for here. We are in the clinic for goodness sake. That's what we've been waiting for!

You could write to ITV Chair Andy Cosslett at andrew.cosslett@itv.com as well as directly to the Dame at carolyn.mccall@itv.com

GLEN with its £47 Billion MCap would certainly be a good JV partner for our hydrogen element at Itumbula. I doubt Gary Nagle does not know about HE1's Itumbula success. Don't forget that Lorna Blaisse is very well connected in the industry and probably knows him. Major helium players such as Linde, Exxon, Messer, APD, Siemens, Air Liquide, Helium24 etc will all be watching developments at Itumbula West closely with a view to a JV with HE1. GLEN, under Gary Nagle, has had a very robust track record of not missing out on the big deals. One to watch.

Yes, I have been here since October. I'm biding my time! I think this is a 2 year investment, at least. However, it is interesting to see the comments on here about ARB. Don't forget that it only took 4 months for ARB to go from 10p to over 300p i.e. October to February for the mega ARB x 100. I was lucky enough to be in part of that mega gain (not all of the mega rise as I bailed out in the end but my ISA and SIPP accounts were very happy!) Another one to remember is NCYT and its whopping x 100. You are right about both HE1 and GST. Both have "Mega Multi-Bag" potential and have already achieved "mini-bags" each already. The GS20 Exchange and Angra look really exciting prospects. NEO Banking / Crypto is the future and GST is going to be a major player. Back to 2p soon before moving onwards to 5p and then the sky is the limit.

As we know last November GST went from sub .70p to over 2p in a couple of days when people started to calculate how the 0.2% fees being charged per transaction on the GS20 Exchange would enhance the bottom line. These 0.2% fees will be racking up healthy income for GST now that we have moved on from the soft launch. We could be looking at big numbers here.

We know this rockets on good news. i.e. ENET is a serious mega multi-bagger when it gets going having risen x 18 before from .25p to 4.5p. We are all watching and waiting for the next big news from David Levi.